PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR
Product Description

ENOXAPARIN PFS 100MG/ML

Read more Show less

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile
Categories
more categories Show less
Specifications
  • Details
    Venus Remedies Ltd has an annual capacity for producing more than 50 lakh units of Enoxaparin, a widely used anticoagulant that prevents blood clots, at its robotic line.

    Read more at:
    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-marketing-approval-for-anticoagulant-drug-in-saudi-arabia/articleshow/103138194.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
  • Selling Points
    Brand Name; Convenience; Ethical Sourcing; Guarantee/Warranty; International Approvals/Standards; Packaging; Product Features; Product Performance; Prompt Delivery; Quality Service; Reputation; Sustainability; CMO/CDMO Contract Research Organisation (CRO) Generics/Biosimilars Manufacturer Manufacturer/Innovator Pharmaceutical company
  • Model
    20 MG | 80 MG | 40 MG | 60 MG
  • Supplied from
    Germany; India
More specifications Fewer specifications
Sales Markets
Show more Show less

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile

More Products from Venus Pharma GmbH (4)

  • ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    Product ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    CEFEPIME FOR INJECTION | CEFTRIAXONE | CEFTAZIDIME FOR INJECTION | CEFOPERAZONE + SULBACTAM FOR INJECTION | CEFUROXIME FOR INJECTION | CEFOTAXIME FOR INJECTION | CEFTAZIDIME AVIBACTAM FOR INJECTION | CEFTRIAXONE SULBACTAM FOR INJECTION | ELORES: CEFTRIAXONE, SULBACTAM & EDTA FOR INJECTION | AZTREONAM F...
  • ONCOLOGY LIQUID INJECTABLES

    Product ONCOLOGY LIQUID INJECTABLES

    CARBOPLATIN | CISPLATIN | CYTARABINE LIQUID | DOCETAXEL WITH SOLVENT | DOCETAXEL (CTD) SINGLE VIAL | DOXORUBICIN | EPIRUBICINE | ETOPOSIDE  | IRINOTECAN | LEUCOVORIN CALCIUM | METHOTREXATE | OXALIPLATIN | PLERIXAFOR | PACLITAXEL  | VINCRISTINE | 5-FLOUROURACIL | FULVESTRANT
  • ONCOLOGY LYOPHILIZED INJECTABLES

    Product ONCOLOGY LYOPHILIZED INJECTABLES

    AZACITIDINE | BENDAMUSTINE  | BLEOMYCIN | BORTEZOMIB | CYTARABINE  | DACARBAZINE | EPIRUBICIN  | GEMCITABINE | PEMETREXED | TOPOTECAN | ZOLENDRONIC ACID
  • OTHER INJECTABLES

    Product OTHER INJECTABLES

    REMDESIVIR FOR INJECTION | ACECLOFENAC | CISATRACURIUM BESYLATE | CITICOLINE | DEXMETOMIDINE | L-ORNITHINE L-ASPARTATE | MIDAZOLAM INJ | N-ACETYLCYSTEINE | SUGAMMADEX| PARACETAMOL

Venus Pharma GmbH resources (2)

  • Venus Remedies Limited has secured vital marketing authorizations for essential medications in three countries.

    News Venus Remedies Limited has secured vital marketing authorizations for essential medications in three countries.

    Venus Remedies Limited has secured vital marketing authorizations for essential medications in three countries. Zoledronic Acid and Paclitaxel will now reach patients in the Philippines, while Bleomycin will become accessible in Saudi Arabia. Azerbaijan also welcomes Enoxaparin sodium injection, marking a significant step towards dismantling healthcare barriers and ensuring patients have access to life-saving solutions. This achievement fuels our mission to improve global health, one approval at a time.
    4 Mar 2024
  • Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and the Philippines

    Brochure Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and the Philippines

    Venus Remedies Limited recently obtained regulatory approval for the marketing of three essential drugs in Saudi Arabia and the Philippines.

    In the dynamic region of Asia, Venus Remedies has received approval for Paclitaxel 100mg/16.7ml and Zoledronic Acid 4mg in the Philippines. These medications are crucial components in the treatment of various medical conditions. Paclitaxel, an anti-cancer drug, is widely used in the management of breast, ovarian, and lung cancers. Zoledronic Acid, a bisphosphonate, is instrumental in the prevention and treatment of bone-related complications in cancer patients, such as fractures and bone pain.